High-performance liquid chromatographic determination of 2′,3′-dideoxycytidine and 3′-azido-3′-deoxythymidine in plasma using a column-switching technique
- 31 December 1988
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 432, 346-351
- https://doi.org/10.1016/s0378-4347(00)80664-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Treatment of human immunodeficiency virus infectionsAntimicrobial Agents and Chemotherapy, 1987
- Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitroAntimicrobial Agents and Chemotherapy, 1986
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985